Clinical Effects of a 6-Month Treatment Course of Ibandronate, Vitamin D, and Calcium in Postmenopausal Women from Central America: Results of a Multinational, Prospective Pilot Study

Publisher： Karger

E-ISSN： 2296-7362|3|1-2|82-88

ISSN： 2296-7362

Source： Integrative Medicine International, Vol.3, Iss.1-2, 2016-08, pp. : 82-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration

By Scharla S.   Oertel H.   Helsberg K.   Kessler F.   Langer F.   Nickelsen T.  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2393-2402

Informa Healthcare

Access to resources Recommend Favorite

Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study

By Recker R.   Weinstein R.   Chesnut C.   Schimmer R.   Mahoney P.   Hughes C.   Bonvoisin B.   Meunier P.  

Osteoporosis International, Vol. 15, Iss. 3, 2004-03 ,pp. : 231-237

Springer Publishing Company

Access to resources Recommend Favorite

Antihypertensive Treatment in Postmenopausal Women: Results from a Prospective, Randomized, Double-Blind, Controlled Study Comparing an ACE Inhibitor (Moexipril) with a Diuretic (Hydrochlorothiazide)

By  

Cardiology, Vol. 89, Iss. 4, 2008-10 ,pp. : 271-276

Karger

Access to resources Recommend Favorite

Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies

By Harris Steven T.   Blumentals William A.   Miller Paul D.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 237-245

Informa Healthcare

Access to resources Recommend Favorite

Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™

By Barrett-Connor E.  

Osteoporosis International, Vol. 23, Iss. 2, 2012-02 ,pp. : 733-741

Springer Publishing Company

Access to resources Recommend Favorite